Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectafer vs IV Iron SOC in Iron Deficiency Anemia
NCT01950247Phase 4Completed
- Sponsor
- American Regent, Inc.
- Start
- Aug 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by American Regent, Inc.. Started Aug 2013; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01950247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01950247.